Literature DB >> 16525063

Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.

Emily A Bates1, Martin Victor, Adriana K Jones, Yang Shi, Anne C Hart.   

Abstract

Expansion of a polyglutamine tract in the huntingtin protein causes neuronal degeneration and death in Huntington's disease patients, but the molecular mechanisms underlying polyglutamine-mediated cell death remain unclear. Previous studies suggest that expanded polyglutamine tracts alter transcription by sequestering glutamine rich transcriptional regulatory proteins, thereby perturbing their function. We tested this hypothesis in Caenorhabditis elegans neurons expressing a human huntingtin fragment with an expanded polyglutamine tract (Htn-Q150). Loss of function alleles and RNA interference (RNAi) were used to examine contributions of C. elegans cAMP response element-binding protein (CREB), CREB binding protein (CBP), and histone deacetylases (HDACs) to polyglutamine-induced neurodegeneration. Deletion of CREB (crh-1) or loss of one copy of CBP (cbp-1) enhanced polyglutamine toxicity in C. elegans neurons. Loss of function alleles and RNAi were then used to systematically reduce function of each C. elegans HDAC. Generally, knockdown of individual C. elegans HDACs enhanced Htn-Q150 toxicity, but knockdown of C. elegans hda-3 suppressed toxicity. Neuronal expression of hda-3 restored Htn-Q150 toxicity and suggested that C. elegans HDAC3 (HDA-3) acts within neurons to promote degeneration in response to Htn-Q150. Genetic epistasis experiments suggested that HDA-3 and CRH-1 (C. elegans CREB homolog) directly oppose each other in regulating transcription of genes involved in polyglutamine toxicity. hda-3 loss of function failed to suppress increased neurodegeneration in hda-1/+;Htn-Q150 animals, indicating that HDA-1 and HDA-3 have different targets with opposing effects on polyglutamine toxicity. Our results suggest that polyglutamine expansions perturb transcription of CREB/CBP targets and that specific targeting of HDACs will be useful in reducing associated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525063      PMCID: PMC6675170          DOI: 10.1523/JNEUROSCI.3344-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

Review 1.  Sin meets NuRD and other tails of repression.

Authors:  P S Knoepfler; R N Eisenman
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

Review 2.  Sir2 links chromatin silencing, metabolism, and aging.

Authors:  L Guarente
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

3.  Three proteins define a class of human histone deacetylases related to yeast Hda1p.

Authors:  C M Grozinger; C A Hassig; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

Authors:  M G Guenther; W S Lane; W Fischle; E Verdin; M A Lazar; R Shiekhattar
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

5.  Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2.

Authors:  H D Youn; L Sun; R Prywes; J O Liu
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

6.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

7.  Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons.

Authors:  Z Mao; M Wiedmann
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

8.  Distinct signaling pathways mediate touch and osmosensory responses in a polymodal sensory neuron.

Authors:  A C Hart; J Kass; J E Shapiro; J M Kaplan
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

9.  The C. elegans homeodomain gene unc-42 regulates chemosensory and glutamate receptor expression.

Authors:  R Baran; R Aronoff; G Garriga
Journal:  Development       Date:  1999-05       Impact factor: 6.868

10.  Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin.

Authors:  J M Boutell; P Thomas; J W Neal; V J Weston; J Duce; P S Harper; A L Jones
Journal:  Hum Mol Genet       Date:  1999-09       Impact factor: 6.150

View more
  72 in total

1.  Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.

Authors:  Zi-Jian Wang; Aoife Hanet; Daniel Weishäupl; Inês M Martins; Anna S Sowa; Olaf Riess; Thorsten Schmidt
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

2.  Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta.

Authors:  Farah H Bardai; Santosh R D'Mello
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 3.  The biological effects of simple tandem repeats: lessons from the repeat expansion diseases.

Authors:  Karen Usdin
Journal:  Genome Res       Date:  2008-07       Impact factor: 9.043

4.  Mitochondrial SIRT4-type proteins in Caenorhabditis elegans and mammals interact with pyruvate carboxylase and other acetylated biotin-dependent carboxylases.

Authors:  Martina Wirth; Samir Karaca; Dirk Wenzel; Linh Ho; Daniel Tishkoff; David B Lombard; Eric Verdin; Henning Urlaub; Monika Jedrusik-Bode; Wolfgang Fischle
Journal:  Mitochondrion       Date:  2013-02-21       Impact factor: 4.160

Review 5.  Models and mechanisms of repeat expansion disorders: a worm's eye view.

Authors:  Paige Rudich; Todd Lamitina
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 6.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Multiple roles of HDAC inhibition in neurodegenerative conditions.

Authors:  De-Maw Chuang; Yan Leng; Zoya Marinova; Hyeon-Ju Kim; Chi-Tso Chiu
Journal:  Trends Neurosci       Date:  2009-09-21       Impact factor: 13.837

8.  Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

Authors:  Darren M Hutt; David Herman; Ana P C Rodrigues; Sabrina Noel; Joseph M Pilewski; Jeanne Matteson; Ben Hoch; Wendy Kellner; Jeffery W Kelly; Andre Schmidt; Philip J Thomas; Yoshihiro Matsumura; William R Skach; Martina Gentzsch; John R Riordan; Eric J Sorscher; Tsukasa Okiyoneda; John R Yates; Gergely L Lukacs; Raymond A Frizzell; Gerard Manning; Joel M Gottesfeld; William E Balch
Journal:  Nat Chem Biol       Date:  2009-12-06       Impact factor: 15.040

9.  Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.

Authors:  Luisa Quinti; Vanita Chopra; Dante Rotili; Sergio Valente; Allison Amore; Gianluigi Franci; Sarah Meade; Marta Valenza; Lucia Altucci; Michele M Maxwell; Elena Cattaneo; Steven Hersch; Antonello Mai; Aleksey Kazantsev
Journal:  PLoS Curr       Date:  2010-09-02

10.  What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?

Authors:  Dawn Teschendorf; Christopher D Link
Journal:  Mol Neurodegener       Date:  2009-09-28       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.